Multiple sclerosis: stem cell therapy reduces symptoms of progressive multiple sclerosis in some people TNA

Response to nerve cell trauma.  Fluorescent light micrograph of a section of a spinal cord affected by multiple sclerosis (MS).  Reactive glial stem cells produce the protein GFAP (glial fibrillary acidic protein, green) and OLIG2 (oligodendrocyte lineage transcription factor 2, red) in an effort to repair damaged nerve cells.  Cell nuclei are dyed blue.  Multiple sclerosis is an autoimmune disease, in which the immune system attacks nerve cells, impairing their ability to relay signals effectively.

Multiple sclerosis causes nerve cell damage that can lead to serious memory and mobility problems


An experimental stem cell therapy may reduce some symptoms of progressive multiple sclerosis, mainly in people severely disabled by the disease.

Multiple sclerosis (MS) is a chronic disease in which the immune system attacks the brain and spinal cord, causing difficulty with walking, memory, bladder control and other bodily functions. When symptoms get progressively worse over time, it is called progressive MS.

There are no approved treatments for progressive MS, but a few small…

highlights  Governments must stay in it for the long haul on long covid research TNA

Leave a Reply

Your email address will not be published. Required fields are marked *